お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、フェイシャルインジェクターの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にフェイシャルインジェクター市場を分類しています。
本レポートでは世界のフェイシャルインジェクター市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Allergan、Merz Aesthetics、Prollenium Medical Technologies、Bloomega BioTechnology、Galderma、Ipsen Group、Suneva Medical、Polymekon、Visionmed、Syneron、Medytox、AQTIS Medical、ColBar LifeScience、SciVision Biotech、Hangzhou Techderm Biological Products、Qufu Guanglong Biochem

レポートはフェイシャルインジェクターの主要生産者を調査し、主要地域や国の消費状況も提供します。フェイシャルインジェクターの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Botox
    Dermal Fillers
    Other

用途別の市場セグメント：
    Hospitals
    Clinics
    Cosmetic Centers
    Other

本レポートの詳細内容
本レポートは、世界のフェイシャルインジェクター市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてフェイシャルインジェクター市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のフェイシャルインジェクター生産量、成長率、市場シェアを調査している。

二. 消費面では、フェイシャルインジェクターの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのフェイシャルインジェクター売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のフェイシャルインジェクター市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本フェイシャルインジェクターのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：フェイシャルインジェクターのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： フェイシャルインジェクターの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるフェイシャルインジェクターの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章フェイシャルインジェクターメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：フェイシャルインジェクターの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：フェイシャルインジェクターの主要メーカーの概要を提供し、製品の説明と仕様、フェイシャルインジェクターの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：フェイシャルインジェクターの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.
The global Facial Injectables market is projected to grow from US$ 10640 million in 2024 to US$ 17690 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period.
In terms of geographical regions, the Americas will be the major market contributor throughout the next few years. The US is the major revenue contributor in this region, where rapid advances in technology, the increasing awareness about aesthetic procedures, and the increasing demand for minimally invasive techniques, will bolster the market’s growth prospects.
Report Covers:
This report presents an overview of global market for Facial Injectables, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Facial Injectables, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Facial Injectables, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Facial Injectables sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Facial Injectables market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Facial Injectables sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Allergan, Merz Aesthetics, Prollenium Medical Technologies, Bloomega BioTechnology, Galderma, Ipsen Group, Suneva Medical, Polymekon and Visionmed, etc.

Market Segmentation
By Company
    Allergan
    Merz Aesthetics
    Prollenium Medical Technologies
    Bloomega BioTechnology
    Galderma
    Ipsen Group
    Suneva Medical
    Polymekon
    Visionmed
    Syneron
    Medytox
    AQTIS Medical
    ColBar LifeScience
    SciVision Biotech
    Hangzhou Techderm Biological Products
    Qufu Guanglong Biochem

Segment by Type
    Botox
    Dermal Fillers
    Other

Segment by Application
    Hospitals
    Clinics
    Cosmetic Centers
    Other

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Facial Injectables in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Facial Injectables manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Facial Injectables sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Facial Injectables Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Botox
    Table 3. Major Manufacturers of Dermal Fillers
    Table 4. Major Manufacturers of Other
    Table 5. Global Facial Injectables Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Facial Injectables Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Facial Injectables Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Facial Injectables Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Facial Injectables Revenue Market Share by Region (2019-2024)
    Table 10. Global Facial Injectables Revenue Market Share by Region (2025-2030)
    Table 11. Global Facial Injectables Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Facial Injectables Sales by Region (2019-2024) & (K Pcs)
    Table 13. Global Facial Injectables Sales by Region (2025-2030) & (K Pcs)
    Table 14. Global Facial Injectables Sales Market Share by Region (2019-2024)
    Table 15. Global Facial Injectables Sales Market Share by Region (2025-2030)
    Table 16. Global Facial Injectables Sales by Manufacturers (2019-2024) & (K Pcs)
    Table 17. Global Facial Injectables Sales Share by Manufacturers (2019-2024)
    Table 18. Global Facial Injectables Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Facial Injectables Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Facial Injectables, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Facial Injectables Price by Manufacturers 2019-2024 (USD/Pcs)
    Table 22. Global Facial Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Facial Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Facial Injectables as of 2023)
    Table 24. Global Key Manufacturers of Facial Injectables, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Facial Injectables, Product Offered and Application
    Table 26. Global Key Manufacturers of Facial Injectables, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Facial Injectables Sales by Type (2019-2024) & (K Pcs)
    Table 29. Global Facial Injectables Sales by Type (2025-2030) & (K Pcs)
    Table 30. Global Facial Injectables Sales Share by Type (2019-2024)
    Table 31. Global Facial Injectables Sales Share by Type (2025-2030)
    Table 32. Global Facial Injectables Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Facial Injectables Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Facial Injectables Revenue Share by Type (2019-2024)
    Table 35. Global Facial Injectables Revenue Share by Type (2025-2030)
    Table 36. Facial Injectables Price by Type (2019-2024) & (USD/Pcs)
    Table 37. Global Facial Injectables Price Forecast by Type (2025-2030) & (USD/Pcs)
    Table 38. Global Facial Injectables Sales by Application (2019-2024) & (K Pcs)
    Table 39. Global Facial Injectables Sales by Application (2025-2030) & (K Pcs)
    Table 40. Global Facial Injectables Sales Share by Application (2019-2024)
    Table 41. Global Facial Injectables Sales Share by Application (2025-2030)
    Table 42. Global Facial Injectables Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Facial Injectables Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Facial Injectables Revenue Share by Application (2019-2024)
    Table 45. Global Facial Injectables Revenue Share by Application (2025-2030)
    Table 46. Facial Injectables Price by Application (2019-2024) & (USD/Pcs)
    Table 47. Global Facial Injectables Price Forecast by Application (2025-2030) & (USD/Pcs)
    Table 48. US & Canada Facial Injectables Sales by Type (2019-2024) & (K Pcs)
    Table 49. US & Canada Facial Injectables Sales by Type (2025-2030) & (K Pcs)
    Table 50. US & Canada Facial Injectables Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Facial Injectables Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Facial Injectables Sales by Application (2019-2024) & (K Pcs)
    Table 53. US & Canada Facial Injectables Sales by Application (2025-2030) & (K Pcs)
    Table 54. US & Canada Facial Injectables Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Facial Injectables Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Facial Injectables Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Facial Injectables Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Facial Injectables Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Facial Injectables Sales by Country (2019-2024) & (K Pcs)
    Table 60. US & Canada Facial Injectables Sales by Country (2025-2030) & (K Pcs)
    Table 61. Europe Facial Injectables Sales by Type (2019-2024) & (K Pcs)
    Table 62. Europe Facial Injectables Sales by Type (2025-2030) & (K Pcs)
    Table 63. Europe Facial Injectables Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Facial Injectables Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Facial Injectables Sales by Application (2019-2024) & (K Pcs)
    Table 66. Europe Facial Injectables Sales by Application (2025-2030) & (K Pcs)
    Table 67. Europe Facial Injectables Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Facial Injectables Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Facial Injectables Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Facial Injectables Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Facial Injectables Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Facial Injectables Sales by Country (2019-2024) & (K Pcs)
    Table 73. Europe Facial Injectables Sales by Country (2025-2030) & (K Pcs)
    Table 74. China Facial Injectables Sales by Type (2019-2024) & (K Pcs)
    Table 75. China Facial Injectables Sales by Type (2025-2030) & (K Pcs)
    Table 76. China Facial Injectables Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Facial Injectables Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Facial Injectables Sales by Application (2019-2024) & (K Pcs)
    Table 79. China Facial Injectables Sales by Application (2025-2030) & (K Pcs)
    Table 80. China Facial Injectables Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Facial Injectables Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Facial Injectables Sales by Type (2019-2024) & (K Pcs)
    Table 83. Asia Facial Injectables Sales by Type (2025-2030) & (K Pcs)
    Table 84. Asia Facial Injectables Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Facial Injectables Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Facial Injectables Sales by Application (2019-2024) & (K Pcs)
    Table 87. Asia Facial Injectables Sales by Application (2025-2030) & (K Pcs)
    Table 88. Asia Facial Injectables Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Facial Injectables Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Facial Injectables Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Facial Injectables Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Facial Injectables Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Facial Injectables Sales by Region (2019-2024) & (K Pcs)
    Table 94. Asia Facial Injectables Sales by Region (2025-2030) & (K Pcs)
    Table 95. Middle East, Africa and Latin America Facial Injectables Sales by Type (2019-2024) & (K Pcs)
    Table 96. Middle East, Africa and Latin America Facial Injectables Sales by Type (2025-2030) & (K Pcs)
    Table 97. Middle East, Africa and Latin America Facial Injectables Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Facial Injectables Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Facial Injectables Sales by Application (2019-2024) & (K Pcs)
    Table 100. Middle East, Africa and Latin America Facial Injectables Sales by Application (2025-2030) & (K Pcs)
    Table 101. Middle East, Africa and Latin America Facial Injectables Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Facial Injectables Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Facial Injectables Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Facial Injectables Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Facial Injectables Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Facial Injectables Sales by Country (2019-2024) & (K Pcs)
    Table 107. Middle East, Africa and Latin America Facial Injectables Sales by Country (2025-2030) & (K Pcs)
    Table 108. Allergan Company Information
    Table 109. Allergan Description and Major Businesses
    Table 110. Allergan Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 111. Allergan Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Allergan Recent Developments
    Table 113. Merz Aesthetics Company Information
    Table 114. Merz Aesthetics Description and Major Businesses
    Table 115. Merz Aesthetics Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 116. Merz Aesthetics Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Merz Aesthetics Recent Developments
    Table 118. Prollenium Medical Technologies Company Information
    Table 119. Prollenium Medical Technologies Description and Major Businesses
    Table 120. Prollenium Medical Technologies Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 121. Prollenium Medical Technologies Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Prollenium Medical Technologies Recent Developments
    Table 123. Bloomega BioTechnology Company Information
    Table 124. Bloomega BioTechnology Description and Major Businesses
    Table 125. Bloomega BioTechnology Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 126. Bloomega BioTechnology Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Bloomega BioTechnology Recent Developments
    Table 128. Galderma Company Information
    Table 129. Galderma Description and Major Businesses
    Table 130. Galderma Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 131. Galderma Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Galderma Recent Developments
    Table 133. Ipsen Group Company Information
    Table 134. Ipsen Group Description and Major Businesses
    Table 135. Ipsen Group Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 136. Ipsen Group Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Ipsen Group Recent Developments
    Table 138. Suneva Medical Company Information
    Table 139. Suneva Medical Description and Major Businesses
    Table 140. Suneva Medical Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 141. Suneva Medical Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Suneva Medical Recent Developments
    Table 143. Polymekon Company Information
    Table 144. Polymekon Description and Major Businesses
    Table 145. Polymekon Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 146. Polymekon Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Polymekon Recent Developments
    Table 148. Visionmed Company Information
    Table 149. Visionmed Description and Major Businesses
    Table 150. Visionmed Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 151. Visionmed Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Visionmed Recent Developments
    Table 153. Syneron Company Information
    Table 154. Syneron Description and Major Businesses
    Table 155. Syneron Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 156. Syneron Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Syneron Recent Developments
    Table 158. Medytox Company Information
    Table 159. Medytox Description and Major Businesses
    Table 160. Medytox Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 161. Medytox Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Medytox Recent Developments
    Table 163. AQTIS Medical Company Information
    Table 164. AQTIS Medical Description and Major Businesses
    Table 165. AQTIS Medical Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 166. AQTIS Medical Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. AQTIS Medical Recent Developments
    Table 168. ColBar LifeScience Company Information
    Table 169. ColBar LifeScience Description and Major Businesses
    Table 170. ColBar LifeScience Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 171. ColBar LifeScience Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. ColBar LifeScience Recent Developments
    Table 173. SciVision Biotech Company Information
    Table 174. SciVision Biotech Description and Major Businesses
    Table 175. SciVision Biotech Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 176. SciVision Biotech Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. SciVision Biotech Recent Developments
    Table 178. Hangzhou Techderm Biological Products Company Information
    Table 179. Hangzhou Techderm Biological Products Description and Major Businesses
    Table 180. Hangzhou Techderm Biological Products Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 181. Hangzhou Techderm Biological Products Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Hangzhou Techderm Biological Products Recent Developments
    Table 183. Qufu Guanglong Biochem Company Information
    Table 184. Qufu Guanglong Biochem Description and Major Businesses
    Table 185. Qufu Guanglong Biochem Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 186. Qufu Guanglong Biochem Facial Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Qufu Guanglong Biochem Recent Developments
    Table 188. Key Raw Materials Lists
    Table 189. Raw Materials Key Suppliers Lists
    Table 190. Facial Injectables Distributors List
    Table 191. Facial Injectables Customers List
    Table 192. Facial Injectables Market Trends
    Table 193. Facial Injectables Market Drivers
    Table 194. Facial Injectables Market Challenges
    Table 195. Facial Injectables Market Restraints
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Facial Injectables Product Picture
    Figure 2. Global Facial Injectables Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Facial Injectables Market Share by Type in 2023 & 2030
    Figure 4. Botox Product Picture
    Figure 5. Dermal Fillers Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Facial Injectables Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Facial Injectables Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Cosmetic Centers
    Figure 12. Other
    Figure 13. Facial Injectables Report Years Considered
    Figure 14. Global Facial Injectables Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Facial Injectables Revenue 2019-2030 (US$ Million)
    Figure 16. Global Facial Injectables Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Facial Injectables Revenue Market Share by Region (2019-2030)
    Figure 18. Global Facial Injectables Sales 2019-2030 ((K Pcs)
    Figure 19. Global Facial Injectables Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Facial Injectables Sales YoY (2019-2030) & (K Pcs)
    Figure 21. US & Canada Facial Injectables Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Facial Injectables Sales YoY (2019-2030) & (K Pcs)
    Figure 23. Europe Facial Injectables Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Facial Injectables Sales YoY (2019-2030) & (K Pcs)
    Figure 25. China Facial Injectables Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Facial Injectables Sales YoY (2019-2030) & (K Pcs)
    Figure 27. Asia (excluding China) Facial Injectables Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Facial Injectables Sales YoY (2019-2030) & (K Pcs)
    Figure 29. Middle East, Africa and Latin America Facial Injectables Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Facial Injectables Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Facial Injectables in the World: Market Share by Facial Injectables Revenue in 2023
    Figure 32. Global Facial Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Facial Injectables Sales Market Share by Type (2019-2030)
    Figure 34. Global Facial Injectables Revenue Market Share by Type (2019-2030)
    Figure 35. Global Facial Injectables Sales Market Share by Application (2019-2030)
    Figure 36. Global Facial Injectables Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Facial Injectables Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Facial Injectables Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Facial Injectables Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Facial Injectables Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Facial Injectables Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Facial Injectables Sales Share by Country (2019-2030)
    Figure 43. U.S. Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Facial Injectables Sales Market Share by Type (2019-2030)
    Figure 46. Europe Facial Injectables Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Facial Injectables Sales Market Share by Application (2019-2030)
    Figure 48. Europe Facial Injectables Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Facial Injectables Revenue Share by Country (2019-2030)
    Figure 50. Europe Facial Injectables Sales Share by Country (2019-2030)
    Figure 51. Germany Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 52. France Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 56. China Facial Injectables Sales Market Share by Type (2019-2030)
    Figure 57. China Facial Injectables Revenue Market Share by Type (2019-2030)
    Figure 58. China Facial Injectables Sales Market Share by Application (2019-2030)
    Figure 59. China Facial Injectables Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Facial Injectables Sales Market Share by Type (2019-2030)
    Figure 61. Asia Facial Injectables Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Facial Injectables Sales Market Share by Application (2019-2030)
    Figure 63. Asia Facial Injectables Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Facial Injectables Revenue Share by Region (2019-2030)
    Figure 65. Asia Facial Injectables Sales Share by Region (2019-2030)
    Figure 66. Japan Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 70. India Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Facial Injectables Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Facial Injectables Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Facial Injectables Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Facial Injectables Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Facial Injectables Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Facial Injectables Sales Share by Country (2019-2030)
    Figure 77. Brazil Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Facial Injectables Revenue (2019-2030) & (US$ Million)
    Figure 82. Facial Injectables Value Chain
    Figure 83. Facial Injectables Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed